Home
About
Overview
Sharing Data
ORCID
Help
History (31)
Molecular pathways and therapeutic targets in lung cancer.
Evidence-based role of bevacizumab in non-small cell lung cancer.
Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysis.
Ureterolithiasis
Circulating tumor cells and serum tumor biomarkers in small cell lung cancer.
See All 31 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Circulating tumor cells and serum tumor biomarkers in small cell lung cancer.
Circulating tumor cells and serum tumor biomarkers in small cell lung cancer. Anticancer Res. 2003 Jan-Feb; 23(1A):49-62.
View in:
PubMed
subject areas
Biomarkers, Tumor
Carcinoma, Small Cell
Humans
Lung Neoplasms
Neoplastic Cells, Circulating
authors with profiles
Ravi Salgia